The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries that suppress drug prices.

Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs administered in doctor’s offices; that move was blocked by a court order.